We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

This study has been terminated.
(PolyMedix decided to stop enrollment in both clinical trials due to observations of reductions in blood pressure.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01312935
First Posted: March 11, 2011
Last Update Posted: May 17, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
PolyMedix, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)